Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts OA Oshagbemi, AM Burden, DCW Braeken, Y Henskens, EFM Wouters, ... American journal of respiratory and critical care medicine 195 (10), 1402-1404, 2017 | 110 | 2017 |
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality OA Oshagbemi, FME Franssen, DCW Braeken, Y Henskens, ... Pharmacoepidemiology and drug safety 27 (11), 1191-1199, 2018 | 26 | 2018 |
Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD) OA Oshagbemi, FME Franssen, S van Kraaij, DCW Braeken, ... COPD: Journal of Chronic Obstructive Pulmonary Disease 16 (2), 152-159, 2019 | 23 | 2019 |
Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis OA Oshagbemi, JHM Driessen, A Pieffers, EFM Wouters, P Geusens, ... Osteoporosis International 28, 2859-2866, 2017 | 22 | 2017 |
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease OA Oshagbemi, AM Burden, KN Shudofsky, JHM Driessen, P Vestergaard, ... Bone 110, 238-243, 2018 | 18 | 2018 |
Absolute blood eosinophil counts to guide inhaled corticosteroids therapy among patients with COPD: systematic review and meta-analysis OA Oshagbemi, JO Odiba, A Daniel, I Yunusa Current Drug Targets 20 (16), 1670-1679, 2019 | 16 | 2019 |
Retinal vasculitis or vascular occlusion after brolucizumab for neovascular age-related macular degeneration: a systematic review of real-world evidence CC Wykoff, H Matsumoto, MR Barakat, H Karcher, A Lozama, A Mayhook, ... Retina, 10.1097, 2022 | 13 | 2022 |
Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013 OA Oshagbemi, SJ Keene, JHM Driessen, R Jordan, EFM Wouters, ... Respiratory Medicine 144, 1-6, 2018 | 11 | 2018 |
Stability of blood eosinophils in COPD and controls and the impact of gender, age, smoking and baseline counts OA Oshagbemi, AM Burden, M Braeken, Y Henskens, EF Wouters, ... Am J Respir Crit Care Med 195 (10), 1402-1404, 2017 | 6 | 2017 |
Estimated distribution of malaria cases among children in sub-Saharan Africa by specified age categories using data from the Global Burden of Diseases 2019 OA Oshagbemi, P Lopez-Romero, C Winnips, KR Csermak, G Su, ... Malaria Journal 22 (1), 371, 2023 | 2 | 2023 |
C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD OA Oshagbemi, FME Franssen, EFM Wouters, AH Maitland-van der Zee, ... Pulmonary pharmacology & therapeutics 60, 101870, 2020 | 2 | 2020 |
Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: the effect of index date selection? JTH Nielen, O Oshagbemi, F de Vries, AM Burden Annals of the rheumatic diseases 75 (5), e26-e26, 2016 | 2 | 2016 |
The role of misclassification of exposure in the association between aspirin and nonsteroidal anti‐inflammatory drug use and keratinocyte cancers. S Abtahi, OA Oshagbemi, A Veelen, R Geel British Journal of Dermatology 181 (3), 2019 | 1 | 2019 |
Retrospective study estimating the incidence of acute alcoholic hepatitis in the United Kingdom OA Oshagbemi, MN Ribeiro, S Behr, O Zorina PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 511-511, 2022 | | 2022 |
Second-generation antipsychotics and pregnancy complications: the impact of confounding by indication OA Oshagbemi, A Daniel, I Yunusa European Journal of Clinical Pharmacology 77, 439-440, 2021 | | 2021 |
Impact of Average Daily and Cumulative Dose of Statins on Mortality Risk Among Healthy Elderly S Abtahi, OA Oshagbemi, A van Veelen The American Journal of Medicine 132 (7), e621, 2019 | | 2019 |
Biomarkers in real-life COPD management OA Oshagbemi | | 2019 |